Loading...
XNAS
SCNX
Market cap1mUSD
Dec 05, Last price  
0.61USD
1D
0.64%
1Q
-31.17%
IPO
-91.73%
Name

TRxADE Health Inc

Chart & Performance

D1W1MN
XNAS:SCNX chart
P/E
0.12
P/S
7.81
EPS
5.18
Div Yield, %
245.90%
Shrs. gr., 5y
56.01%
Rev. gr., 5y
-55.04%
Revenues
137k
-98.35%
000806,047955,8811,496,2274,992,2032,481,8662,931,2803,831,7787,436,26417,122,5209,889,43311,448,2658,272,214136,643
Net income
9m
P
-8,725-28,186-28,497,000-150,713-2,091,285-2,012,043-1,117,183-2,760,125288,9839,038-409,730-2,565,440-4,113,047-4,310,205-17,843,5749,065,798
CFO
-14m
L+587.95%
-6,225-16,068-28,164,000-163,118-844,579-1,064,576-1,202,137-1,313,418171,670273,386141,775-2,214,786-2,566,226-1,525,929-2,073,601-14,265,238
Dividend
Jul 19, 20241.5 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
IPO date
Feb 18, 2020
Employees
33
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT